Subscribe to stay informed!
Devon-based Zynerba is set to be acquired by Harmony Biosciences Holdings in a $2 million deal, writes John George for the Philadelphia Business Journal…
Aclaris Therapeutics, a Chester County specialty pharmaceutical company focused on treating skin disorders, is seeking to raise up to $86.25 million in its IPO…
Zynerba Pharmaceuticals is still experiencing a rollercoaster ride on the NASDAQ under the ticker ZYNE, since launching its more than fully subscribed Initial Public Offering…
Before we send you to this site, please subscribe to our daily newsletter.